Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with Non-Hodgkin-Lymphoma (NHL): results from an interim analysis of the non-interventional study NADIR.

Fietz, T., Wolff, T., Schulz, H., Sandner, R., Reichert, D., Hurtz, H.-J., Müller, J., Grebhardt, S., 2016.

Oncol Res Treat, DGHO-Jahrestagung (Leipzig) 39 (suppl3)(P950), 292. doi:10.1159/000449050

Studie: NADIR; Indikation: Hämoblastosen; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com